Vivus

Vivus Could Surge On Qnexa Approval
Motley Fool
Sat, 04/14/12 - 12:25 pm
Vivus
Qnexa
obesity
Handicapping The Obesity Race
Seeking Alpha
Wed, 04/11/12 - 10:59 am
obesity
Vivus
Arena Pharmaceuticals
Orexigen
Vivus Tumbles On Extended FDA Review
Barron's
Tue, 04/10/12 - 11:08 am
FDA
Vivus
Qnexa
obesity
FDA will take 3 more months to review Vivus drug
Yahoo/AP
Mon, 04/9/12 - 05:43 pm
Vivus
FDA
Qnexa
obesity
Vivus: Ready To Gain From Qnexa
Seeking Alpha
Mon, 04/9/12 - 11:57 am
Vivus
Qnexa
obesity
JNJ
Novartis
Pfizer
Teva Pharmaceuticals
Vivus' ED Drug Will Make Investors Money
Motley Fool
Thu, 04/5/12 - 09:11 pm
erectile dysfunction
Vivus
Avanafil
Focus On Upcoming FDA Drug Approval And Advisory Dates
Seeking Alpha
Wed, 04/4/12 - 11:18 am
FDA
XenoPort
Horizant
lorcaserin
Arena Pharmaceuticals
Qnexa
Vivus
Protalix BioTherapeutics
GSK
taliglucerase
For Biotech Takeovers, Timing is Key
TheStreet.com
Wed, 04/4/12 - 08:44 am
M&A
biotech
Vivus
Arena Pharmaceuticals
Discovery Labs
3 Anti-Obesity Drug Companies Poised To Grow
Seeking Alpha
Tue, 04/3/12 - 08:59 am
obesity
Vivus
Orexigen
lorcaserin
Arena Pharmaceuticals
Contrave
Qnexa
Another Option Strategy For Vivus
Seeking Alpha
Tue, 04/3/12 - 08:58 am
Vivus
options
Sector Snap: Obesity drug companies
Yahoo/AP
Sat, 03/31/12 - 11:49 am
Orexigen
Vivus
lorcaserin
Qnexa
Arena Pharmaceuticals
Contrave
obesity
Vivus, Arena Unlikely to Be Affected by FDA Obesity Panel
Bloomberg
Fri, 03/30/12 - 12:00 pm
Arena
Vivus
FDA
obesity
advisory panels
Orexigen
Will Obesity Drugs Do Better in Europe?
Motley Fool
Thu, 03/29/12 - 12:16 pm
obsesity
Arena
Vivus
Orexigen
lorcaserin
Contrave
Qnexa
Large Market Opportunity Emerges For Oculus Technology
Seeking Alpha
Wed, 03/28/12 - 10:19 am
Oculus
GSK
JNJ
Novartis
Sanofi
Vivus
Obesity Drugs May Need Heart Risk Studies Before Approval
Bloomberg
Mon, 03/26/12 - 12:22 pm
obesity
Vivus
Arena Pharmaceuticals
Orexigen
Qnexa
VIVUS Announces Acceptance of Avanafil Application in Europe
Yahoo
Mon, 03/26/12 - 12:20 pm
Vivus
Avanafil
Europe
erectile dysfunction
20 Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Sun, 03/25/12 - 11:38 am
Achillion
Amylin
Ariad Pharmaceuticals
Aveo Pharmaceutical
Cell Therapeutics
EXACT Sciences
Idenix
Exelixis
Halozyme
Lexicon Pharmaceuticals
Nektar
Momenta
ONYX Pharmaceuticals
Optimer Pharmaceuticals
PDL Biopharma
Questcor Pharmaceuticals
Santarus
Spectrum Pharmaceuticals
Regeneron
Vivus
A Picture is Worth a Thousand Words: The Difference Between "Yes" and "No" During an FDA Advisory Committee
Elsevier Business
Fri, 03/9/12 - 10:49 am
FDA
advisory panels
Xgeva
Amgen
Vivus
Qnexa
9 Biotech Stocks With Significant Liquidity Growth
Seeking Alpha
Sat, 03/3/12 - 11:12 am
Corcept Therapeutics
Hi Tech Pharmacal
Questcor Pharmaceuticals
Myriad Genetics
QLT Inc
Valeant Pharmaceuticals
Rigel Pharmaceuticals
Techne
Vivus
Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash
TheStreet.com
Fri, 03/2/12 - 10:10 am
Cyclacel
Vivus
Celldex
Astex
Discovery Labs
Exelixis

Pages